Neoadjuvant chemotherapy less commonly used in breast cancer

Published Date: 02 Mar 2023

Most women will have breast cancer surgery first if the initial consultation is with a surgeon. This study has been published as a preprint and has not yet been peer-reviewed.

Read Full News

Latest News

Middle East Tensions Endanger Hospital Supply Chains

A 30%-50% spike in US drug prices would strain hospital budgets for biologics and oncology drugs; Spanish hospitals plan biosimilars, renegotiations, and prioritization measures.

Catholics May receive Organ Transplants From Animals, Vatican Says

The Vatican said on Tuesday that Catholics can receive transplants ⁠of animal tissues to address medical conditions, as procedures involving genetically modified pig or cow...

Lifelike 3D-Printed ‘Training Brains’ React Like Real Organs

Researchers create a new polymer that mimics the mechanical, thermal, and electromagnetic properties of brain tissue, driving new surgical and experimental uses.

Nerve Wrap Seen Speeding Erectile Recovery Post-Prostatectomy

Dehydrated human amniotic membrane appears promising in observational findings from a large dataset.

Stryker Cyberattack Delays Surgeries for Some Patients, Bloomberg News Reports

A cyberattack against medical device maker Stryker last ⁠week has delayed surgeries for some patients, Bloomberg News ⁠reported on Wednesday.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Todays Updates

Insulin Resistance Detected Early May Guide HS Therapy

Screening for insulin resistance early after the diagnosis of hidradenitis suppurativa shows promise for guiding therapies to improve the disease course.

Dermatomyositis: Targeted Drug Shows Promise vs Placebo

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Melasma: A New Era of Topical Treatment Options Galore

Combination therapies remain key as multiple agents for melasma hit the market.

LAAC an Alternative for NOAC in Lower-Risk AF Patients

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Fibrinolytic Beats Current Standard for Intermediate-Risk PE

For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy.

PCKS9 Inhibitors Seen Driving Down LDL-C in Diabetes

A subgroup analysis of the VESALIUS-CV trial showed evolocumab significantly cut LDL cholesterol and cardiovascular event risk in people with diabetes but no known atherosclerosis.

High Dx Yield Supports Workup for INOCA

Performed with favorable safety, the diagnostic yield for coronary function testing in patients with ischemia but nonobstructive arteries was found to exceed 90%.

Latest News

A 30%-50% spike in US drug prices would strain hospital budgets for biologics and oncology drugs; Spanish hospitals plan biosimilars, renegotiations, and prioritization measures.

The Vatican said on Tuesday that Catholics can receive transplants ⁠of animal tissues to address medical conditions, as procedures involving genetically modified pig or cow...

Researchers create a new polymer that mimics the mechanical, thermal, and electromagnetic properties of brain tissue, driving new surgical and experimental uses.

Dehydrated human amniotic membrane appears promising in observational findings from a large dataset.

A cyberattack against medical device maker Stryker last ⁠week has delayed surgeries for some patients, Bloomberg News ⁠reported on Wednesday.

News All Time

MRI-Guided Chemotherapy Improves Survival in Breast Cancer

MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.

NICE Backs Paperclip-Sized Sensor for Heart Failure Care

The CardioMEMS HF System enables daily home monitoring and has been shown to reduce hospital admissions in high-risk patients with chronic heart failure.

Which Imaging Method Best Detects At-Risk MASH?

Noninvasive imaging tests may help identify at-risk metabolic dysfunction-associated steatohepatitis, with a FibroScan-based scoring system performing best among commonly used methods.

Dual Biologics May End Daily Pills Post-Kidney Transplant

A novel dual biologic regimen combining dazodalibep and belatacept is well tolerated and could enable more than half the kidney transplant recipients to avoid broader metabolic pathway inhibitors.

Physician Shortage: Give Nurses a Shot?

Abundant randomized trial data support using nurses instead of physicians in certain healthcare roles, but does that mean we should do it?

Vaccination at All Ages Is Crucial and Safe, Says Ethicist

Ethicist Art Caplan discusses federal vaccine policy changes in the United States.

FMT May Clear Drug Resistant Pseudomonas in Blood Cancer

Faecal microbiota transplantation appears to be effective in decolonising carbapenem-resistant Pseudomonas and is safe in patients with hematologic malignancies, a retrospective analysis shows.

Heart Device Rivals Transplant Survival in Young HF Patients

Implantation of a left ventricular assist device offers survival outcomes similar to heart transplantation in young patients with advanced heart failure, a study finds.

Cheap Surgery Abroad Leaves NHS With Big Bills

Patients returning with serious complications after overseas procedures may be costing the NHS thousands, but the full impact remains unclear.

Alpha-Lipoic Acid Linked to Modest Benefit in Ischemic HF

Alpha-lipoic acid added to standard care in ischemic heart failure shows similar event rates and safety as placebo, with modest gains in heart function and walking capacity.

13 Doctors Celebrate Their Mentors

Thirteen doctors honor their most formative professional relationships.

Inside the Care of Patients With Severe Burns

From fluid resuscitation to grafting, clinicians face challenges in managing severe burns in highly specialized hospital units.

Bromelain and Antibiotics Aid Crans-Montana Burn Care

Experience from Crans-Montana shows how rapid eschar removal and targeted antimicrobials can reduce the surgical burden and complications in patients with severe burn injuries.

Expert Algorithm Offered for Treating Lichen Planopilaris

Optimized treatment of lichen planopilaris should be individualized in the context of presenting symptoms and features, according to a newly tweaked algorithm.

Skin Penetration Enhancers

Current research considers multiple factors in divining the optimal approaches and ingredients for enhancing the penetration of drugs, cosmetics, and cosmeceuticals into the skin.

New Data on Antidepressants and Bleeding Risk in TBI

A population-based study explores the relationship between preinjury antidepressant use and short-term outcomes after traumatic brain injury.

Recommended News For You

An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.

AI innovation unlocks non-surgical way to detect brain cancer spread

Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

Cancer Warnings on Alcohol? Surge in GI Illnesses; Swab Detects Kids' Asthma Type

Recommended Articles For You

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies 

Unlocking the Power of Cryoprecipitate: A Comprehensive Guide 

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights 

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel Agent for Chronic GVHD Wins FDA Approval

2.

According to the Lancet, having cancer and VTE at the same time increases mortality risk.

3.

Pancreatic cancer patients who were prescribed lorazepam for anxiety had poorer survival rates.

4.

New research demonstrates a method for screening people at high risk for pancreatic cancer.

5.

'Converging' Evidence of Link Between Air Pollution and Breast Cancer

1.

Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy

2.

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs

3.

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

4.

HPV Infection Review: Epidemiology, Risks, and Therapeutic Advances for Clinicians

5.

The benefits and risks of taking fludrocortisone for adrenal insufficiency 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion

2.

First Line Combination Therapy- The Overall Survival Data in NSCLC Patients

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III

4.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

5.

Efficient Management of First line ALK-rearranged NSCLC - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot